Indivior PLC is a prominent biopharmaceutical company based in North Chesterfield, Virginia, specializing in the development of innovative treatments for opioid dependence and related disorders. Renowned for its pioneering buprenorphine-based therapies, Indivior is dedicated to enhancing patient outcomes while addressing the multifaceted challenges of opioid use disorder. The company's strong commitment to public health is reflected in its significant investments in research and development, solidifying its role as a leader in addiction treatment. With a comprehensive product portfolio and a patient-centric focus, Indivior is strategically positioned to meet the dynamic needs of the healthcare landscape. Show more
Location: 10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, UNITED STATES, 23235, North Chesterfield, VA, 23235, USA | Website: https://www.indivior.com | Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC | Sector: HEALTHCARE
Market Cap
4.183B
52 Wk Range
$7.62 - $38.00
Previous Close
$33.46
Open
$34.18
Volume
1,427,377
Day Range
$33.46 - $34.48
Enterprise Value
4.096B
Cash
445M
Avg Qtr Burn
-41.96M
Insider Ownership
0.36%
Institutional Own.
71.13%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
